 ROSEVILLE, Minn., Oct. 5, 2021 PRNewswire -- Calyxt, Inc. Nasdaq: CLXT, a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the Company on engineering synthetic biology solutions for a diversified base of customers across an expanded group of end markets including the nutraceutical, cosmeceutical, pharmaceutical, advanced materials, and chemical industries. 